Free tool
Oncology stocks
We cover 4 companies grouped under the Oncology theme. The median market value in the group is $12.40M. Across the group, the median move over the past trading day is +1.35%. Price change over the past year runs from −78.9% to −11.5% across the middle 80 percent of the group, with a median of −49.7%.
Other lists in this group
SaaSAI applicationsCybersecuritySemiconductor designSemiconductor equipmentFintech softwarePayment processingEcommerce marketplacesStreaming mediaGaming softwareOncologyRare diseaseMedical devicesCell therapyDiagnosticsRegional banksAsset managementGold miningCryptocurrency and digital assetsSpecialty chemicalsAll stocks
Table
4 of 319 companies match these filters.Clear filters
| Ticker | Company | Market cap (USD) | Size | 1Y return | Next report |
|---|---|---|---|---|---|
| KPTI | Karyopharm Therapeutics Inc. Common Stock | $42.19M | Micro cap | −69.57% | Nov 3, 2026 |
| PDSB | PDS Biotechnology Corporation | $12.40M | Micro cap | −82.96% | Nov 12, 2026 |
| CRIS | Curis, Inc. | $3.86M | Micro cap | −3.64% | Nov 5, 2026 |
| 0HS8.L | Lisata Therapeutics, Inc. | — | — | −29.74% | Nov 5, 2026 |
Covers ~22,000 companies across the US, Europe and Asia-Pacific (ex mainland China, Hong Kong and India), refreshed nightly. Every listed stock opens as a full analysis for $9.90.